One in 8 adults has used Ozempic or similar GLP-1 drugs

Published



Nearly 1 in 8 adults in the United States has used a GLP-1 drug, such as Ozempic or Mounjaro, according to new survey data from healthcare policy think tank KFF.

According to the survey, 12% of adults reported taking the revolutionary class of drugs to lose weight or treat chronic conditions, such as heart disease or obesity.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.